Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

DIFFISORT

Financiado

Cerrado

Characterization of a major family of cell wall proteins of Clostridium difficil...

Characterization of a major family of cell wall proteins of Clostridium difficile the sortase family "Clostridium difficile infection (CDI) represents the most problematic hospital acquired infection in Europe. It is also increasingly recognized as a community-associated disease. Current treatments for C. difficile disease are in... ver más

14/08/2014

IMPERIAL COLLEGE O...

200K€

Presupuesto del proyecto: 200K€

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2014-08-14 No tenemos la información de la convocatoria

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

IMPERIAL COLLEGE OF SCIENCE...

0.00€ | Lider

Proyectos interesantes

MUCDIFF

Medical Technol...

Microbiology

166K€ Cerrado

ELFBAD

Medical Technol...

Biotechnology

2M€ Cerrado

Septal_PG_Hydrolases

Medical Technol...

Biotechnology

Cerrado

BFU2011-25326

Medical Technol...

Biotechnology

288K€ Cerrado

Regenerate

Medical Technol...

Biotechnology

201K€ Cerrado

PID2019-105126RB-I00

Medical Technol...

Biotechnology

145K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND ME... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 200K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "Clostridium difficile infection (CDI) represents the most problematic hospital acquired infection in Europe. It is also increasingly recognized as a community-associated disease. Current treatments for C. difficile disease are inadequate and other strategies must be found to treat or prevent disease. C. difficile is an anaerobic Gram-positive, spore-forming enteric pathogen. After disruption of the intestinal barrier by antibiotics, spores of C. difficile germinate and bacteria multiply in the intestine. Toxins are released and cause symptoms of disease which include diarrhea, or in the worst case, pseudomembranous colitis.The crucial early step of C. difficile infection is colonization of the intestine. C. difficile, like most bacterial pathogens, displays proteins on its surface that may act as adhesins and facilitate interaction with the host in order to allow colonization. Gram-positive bacteria predominantly use their thick cell wall as a platform for display of surface proteins. Cell wall surface proteins can be covalently linked to the peptidoglycan by a sortase enzyme, a membrane-associated transpeptidase. Sortase enzymes and their substrates are promising therapeutic targets for the development of novel antibiotics. To date no sortase enzyme or substrates have been described in C. difficile, although we have identified several sortase and sortase substrate genes within the genome. The project described here will investigate the role of the C. difficile sortase enzyme and sortase substrates. A variety of state-of-the art techniques will be used to explore these proteins, including advanced molecular genetics, in vivo animal models of infection and structural biology. The characterization of sortase enzymes and sortase substrates will allow firstly a better understanding of the colonization process of C. difficile and secondly will allow the identification of new virulence factors, which constitute potential vaccine components."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores